Hardly a week goes by without Topcon Healthcare, a US subsidiary of Japan-based Topcon Corporation, announcing a new acquisition or initiative in the domain of oculomics, i.e. “the blending of big data, artificial intelligence (AI), and ocular imaging to identify retinal biomarkers of systemic disease” by the definition of ...

Buying a membership today will give you:
To continue reading this article register now.